Discovery of 1,5-Benzodiazepines with Peripheral Cholecystokinin (CCK-A) Receptor Agonist Activity (II): Optimization of the C3 Amino Substituent
Gavin C. Hirst, Christopher J. Aquino, Lawrence Birkemo et al. · Journal of Medicinal Chemistry · 1996
Analogs of the previously reported 1,5-benzodiazepine peripheral cholecystokinin (CCK-A) receptor agonist 1 were prepared which explore substitution and/or replacement of the C-3 phenyl urea moiety. Agonist efficacy on the isolated guinea pig gallbladder (GPGB) was retained with a variety of substituted ureas and amide analogs. Three compounds were identified which were orally active in the mouse gallbladder emptying assay (MGBE). The 2-indolamide (52) and N-(carboxymethyl)-2-indolamide (54) derivatives had improved affinity for the human CCK-A receptor but reduced agonist efficacy on the GPGB. Neither indolamide was orally active in a rat feeding assay. In contrast, the (3-carboxyphenyl)urea derivative (29, GW7854) had moderately increased affinity for the human CCK-B receptor but was a potent full agonist on the GPGB and was orally active in both the MGBE and rat feeding assays. GW7854 was a full agonist (EC50 = 60 nM) for calcium mobilization on CHO K1 cells expressing hCCK-A receptors and a potent antagonist of CCK-8 (pA2 = 9.1) on CHO K1 cells expressing hCCK-B receptors. GW7854 is a potent mixed CCK-A agonist/CCK-B antagonist which is orally active in two in vivo models of CCK-A-mediated agonist activity.
Cited by 37 works. doi:10.1021/jm9601664
Authors
- Gavin C. Hirst
- Christopher J. Aquino
- Lawrence Birkemo
- Dallas K. Croom
- Milana Dezube
- Gregory N. Ervin
- Mary K. Grizzle
- Brad R. Henke
- Michael K. James
- Michael F. Johnson
- Tanya M. Momtahen
- Kennedy L. Queen
- Ronald G. Sherrill
- Jerzy Szewczyk
- Timothy Mark Willson
- Elizabeth E. Sugg
References
- Chemistry of the amino acids
- Protective groups in organic synthesis
- Methods for drug discovery: development of potent, selective, orally effective cholecystokinin antagonists
- C-terminal octapeptide of cholecystokinin decreases food intake in man
- Biological actions of cholecystokinin
- Rationale for the synthesis and preliminary biological evaluation of highly active new antitumor nitrosoureido sugars
- Evidence that decreased feeding induced by systemic injection of cholecystokinin is mediated by CCK-A receptors
- Discovery of 1,5-Benzodiazepines with Peripheral Cholecystokinin (CCK-A) Receptor Agonist Activity. 1. Optimization of the Agonist “Trigger”
- New molecular forms of cholecystokinin. Microsequence analysis of forms previously characterized by chromatographic methods.
- Antispasdomic activity on the gallbladder of the mouse of CR 1409 (Lorglumide) a potent antagonist of peripheral CCK